HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Policy

Regulation of AI in Prior Authorization and Claims Review: A Look at Federal and State Consumer Protections

Amid the growing use of artificial intelligence (AI) in the claims review cycle, this brief discusses the types of consumer protections for use of AI in prior authorization and claims review, describes the Trump administration’s general approach to AI , and highlights areas to watch as Congress cons

By KFF Health News · May 6, 2026 · via KFF Health News
Regulation of AI in Prior Authorization and Claims Review: A Look at Federal and State Consumer Protections

Image: KFF Health News

This is an aggregated industry headline. Read the full story at KFF Health News →

Tags
policyformat:headlineheadlineKFF Health News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Policy
All Policy →
Capricor’s Lawsuit Against NS Pharma Exposes Fragile Cell Therapy Commercial Models
PolicyBriefing
Capricor’s Lawsuit Against NS Pharma Exposes Fragile Cell Therapy Commercial Models
With FDA review of deramiocel approaching, Capricor alleges NS Pharma halted launch prep and failed to fix a p…
May 10, 2026
Experts wonder ‘Where is the CDC?’ as hantavirus outbreak unfolds
PolicySTAT News ↗
Experts wonder ‘Where is the CDC?’ as hantavirus outbreak unfolds
The CDC is playing an unusually small, and quiet, role in responding to the hantavirus outbreak.…
May 9, 2026
Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
PolicyFiercePharma ↗
Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
During the weeklong stay by the Supreme Court to temporarily restore online access to the abortion pill mifepr…
May 9, 2026